title: A CT scan aspect of "hypodense thyroid gland" after sunitinib treatment for metastatic carcinoma of the kidney.
authors.affiliation: Department of Endocrinology, University Hospital of Pointe-à-Pitre, Guadeloupe, French West Indies. fritz-line.velayoudom@chu-guadeloupe.fr
authors.forename: Fritz-Line
authors.initials: FL
authors.lastname: Vélayoudom-Céphise
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Vian
authors.forename: Théo
authors.initials: T
authors.lastname: Bosewa
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Nallet
authors.forename: Jean-Louis
authors.initials: JL
authors.lastname: Wemeau
authors.forename: Jean-Paul
authors.initials: JP
authors.lastname: Donnet
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006042:Goiter / Q000209:etiology / Q000473:pathology; D006801:Humans; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000473:pathology*; D011758:Pyrroles / Q000009:adverse effects* / Q000627:therapeutic use; D000077210:Sunitinib; D013960:Thyroid Function Tests; D013961:Thyroid Gland / Q000000981:diagnostic imaging*; D013971:Thyrotoxicosis / Q000139:chemically induced* / Q000473:pathology*; D014057:Tomography, X-Ray Computed
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib